The FDA has not found any evidence of personality changes, but many clinical studies show the potential risk of worsening mental health issues while using Ozempic
Intermittent dosing creates trough periods where appetite returns and food intake spikes, which may explain why anecdotal reports of strategic dosing dont consistently lead to maintained weight loss
Micronutrient deficiencies observed in individuals with obesity could be a function of poor diet, with decreased intake of vitamins and minerals (Astrup & Bgel, 2019)
People who took weight-loss drugs regained about a pound (0.4 kilogram) a month on average after they stopped treatment
Bailly M, Destrieux C, Hommet C, Mondon K, Cottier JP, Beaufils E, et al